LatAm A roundup of some of the latest news from Latin American pharma, including Acino’s acquisition of M8 Pharmaceuticals; AstraZeneca’s growth in Mexico; Neuraxpharm’s expansion into Brazil and Mexico, and Columbia’s decision to issue a compulsory license for GSK/ViiV’s HIV treatment. Colombia set to issue a compulsory license for an…
China Ongoing geopolitical tensions between China and the West have led the G7 group of countries to warn of the threat of “economic coercion” from China and the US to scrutinise Chinese investment in its biotech sector more closely. Against this backdrop, and despite many of the leading lights in global…
Hong Kong AstraZeneca, the largest overseas pharmaceutical company in mainland China by sales, is also the market leader in Hong Kong and Macau, a territory overseen by General Manager Shan Wu. She outlines the fundamentals behind the company’s success in Greater China, how AstraZeneca is working to bolster Hong Kong’s innovation and…
China A roundup of some of the latest healthcare and pharma news from China including a crackdown on healthcare corruption; AstraZeneca’s cardiovascular mortality drug approval and mRNA manufacturing deal with CanSino; Tigermed’s new Hong Kong HQ; GenScript Biotech/T-Maximum Biotech CAR-T agreement, and the Chinese cabinet’s renewed efforts to encourage foreign biotech…
Global The top 20 pharmaceutical companies in the world for the past year, according to Pharmaceutical Executive’s latest annual rankings. Pfizer holds sway at the top of the leaderboard, with its BioNTech-partnered COVID-19 vaccine Comirnaty still generating an incredible USD 37.8 billion in 2022 and its COVID-19 antiviral Paxlovid adding a…
USA Big Pharma has been raging against the US’s Inflation Reduction Act (IRA) ever since it was passed last year. Merck (MSD global) has recently taken its indignation a step further and sued the US government, arguing that the new legislation violates the constitution, but shareholders at the ICCR are not…
China A roundup of some of the most significant recent stories from the Chinese pharmaceutical industry, including a slate of international investment which seems to suggest that – despite ongoing political tensions – China remains an attractive market for multinational pharma. AstraZeneca defies geopolitics to bet on China – Financial…
Belgium During the COVID-19 pandemic and the multi-stakeholder collaboration needed to find solutions, AstraZeneca launched the Partnership for Health System Sustainability and Resilience (PHSSR) in collaboration with KPMG, the London School of Economics and Political Science (LSE), Royal Philips, the World Economic Forum (WEF), the Center for Asia-Pacific Resilience & Innovation…
China A roundup of some of the biggest pharma and biotech news from China including the collaboration between Elektr and Sinopharm; Biocytogen’s partnership with Janssen and deal with Chipscreen Biosciences; China’s first personalised neoantigen-targeted cancer vaccine approval; the final green light for Sino Biopharm’s purchase of F-star, and AstraZeneca’s deal with…
UAE A roundup of the latest pharma news from the United Arab Emirates (UAE) including Julpher’s pursuit of its growth strategy with a new CEO, Global Pharma’s tech transfer deal with Egypt’s Nerhado and Pharma Solutions’ procurement of its first thalassemia generic. AstraZeneca announces move to Dubai Science Park with…
Thailand The top ten companies in the USD 6.9 billion Thai pharma market for 2021 ranked by market share, compiled by Thai banking firm Krungsti. Three of the featured firms – Mega Lifesciences, Better Pharma, and Berlin Pharma – are locals, while multinationals of the likes of AstraZeneca, Pfizer, and Novartis…
USA After Big Pharma lobby groups suffered a major drug pricing blow earlier this year with the passage of the US Inflation Reduction Act (IRA), pharma industry heavyweight AbbVie is withdrawing its membership to leading industry trade groups PhRMA and BIO. AbbVie Bows Out AbbVie is leaving both of the…
See our Cookie Privacy Policy Here
